key: cord-0898791-jp63gh0t
authors: Barbieri, Pierluigi; Zupin, Luisa; Licen, Sabina; Torboli, Valentina; Semeraro, Sabrina; Cozzutto, Sergio; Palmisani, Jolanda; Di Gilio, Alessia; de Gennaro, Gianluigi; Fontana, Francesco; Omiciuolo, Cinzia; Pallavicini, Alberto; Ruscio, Maurizio; Crovella, Sergio
title: “Molecular detection of SARS-CoV-2 from indoor air samples in environmental monitoring needs adequate temporal coverage and infectivity assessment”
date: 2021-04-24
journal: Environ Res
DOI: 10.1016/j.envres.2021.111200
sha: 11717cc4dc492a32cb81cc66df9ffd379668856c
doc_id: 898791
cord_uid: jp63gh0t

The relevance of airborne exposure to SARS-CoV-2 in indoor environments is a matter of research and debate, with special importance for healthcare low-risk settings. Experimental approaches to the bioaerosol sampling are neither standardized nor optimized yet, leading in some cases to limited representativity of the temporal and spatial variability of viral presence in aerosols. Airborne viral viability moreover needs to be assessed. A study has been conducted collecting five 24-hours PM10 samples in a COVID-19 geriatric ward in late June 2020, and detecting E and RdRp genes by RT-qPCR with a Ct between 36 and 39. The viral RNA detection at Ct=36 was related to the maximal numerosity of infected patients hosted in the ward. Lacking a direct infectivity assessment for the collected samples an experimental model has been defined, by seeding twelve nasopharyngeal swab extracts from COVID-19 positive patients on Vero E6 cells; only the four extracts with a viral load above E+10 viral copies (approximately Ct<24) have been able to establish a persistent infection in vitro. Therefore, the cytopathic effect, a key feature of residual infectivity, could be considered unlikely for the environmental PM10 samples showing amplification of viral RNA at Ct = 36 or higher. A standardization of airborne SARS-CoV-2 long-term monitoring and of environmental infectivity assessment is urgently needed.

Healthcare facilities hosting patients affected by coronavirus disease 2019 are critical hotspots for potential infection and diffusion of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), due to the possible viral spread through respiratory or aerosol droplets (Tellier, 2019; Razzini et al. 2020; Lednicky et al. 2020; Chia et al. 2020; Milton, 2020) ; the relevance of infection by fomites has been recently reduced (Goldman, 2020) . Respiratory droplets are usually defined as drops characterized by a diameter >5 μm and with a range of dissemination of 1 meter, thus being able to transfer virions to surfaces generating fomites. Another way of transmission that needs to be considered is the airborne way of infection (Morawska et Cao 2020; Morawska et Milton, 2020) through aerosol droplets that are particles presenting a diameter <5 μm with a potential release of several meters for prolonged time (minutes until hours) (Sommerstein et al. 2020; Setti et al. 2020a) .

Notably, the 5 μm threshold has been questioned (Prather et al., 2020; Buonanno et al. 2020) , and relevance of bioaerosol particles of smaller size -constituting the so-called inhalable fraction of particulate matter having long residence time in air -in the COVID 19 spread is supported (Lee, 2020) with implications for the healthcare workers protection in both low and high risk settings (Zhang et Duchaine, 2020) . SARS-CoV-2 airborne transmission in close environments is still a subject of debate in the scientific community and further research efforts are needed to completely clarify this issue, despite general evidence of potential effects (Wei, 2016) .

As a matter of fact, several sampling approaches and devices are available for the collection and detection of airborne viruses (Rahmani et al. 2020; Pan et al. 2019) . In a recent work, Comber et al. (2020) reviewed 16 articles reporting results about the collection of air samples and associated SARS-CoV-2 detection in healthcare facilities. Intensive care units (ICU) have been often considered, while less attention has been addressed to low risk settings or to general wards.

Examining the methods used in the literature, it can be observed that there is a broad variety of combination of the following experimental setup parameters: sampling devices, supports for the sample collection, sampling time, air flow, sampler positioning, number of days of repeated sampling, time/s of the day selected for sampling, number of samples collected repeatedly at the same sampling point, SARS-CoV-2 detection methods. Nine studies (Chia et al., 2020; Guo et al. 2020; Jiang et al. 2020; Lei et al. 2020; Razzini et al. 2020; Santarpia et al. 2020a; Santarpia et al. 2020b; Zhou et al. 2020 ) present in the above mentioned review as also further studies published (Ding et al. 2021; Feng et al. 2021; Kenarkoohi et al. 2020) found from 3.6 % to 100 % samples J o u r n a l P r e -p r o o f positive for SARS-CoV-2 RNA with a total number of samples collected ranging from six to sixtyfive (see Table SM1 in the Supplementary Material for details), having shown feasibility of SARS-CoV-2 RNA detection from environmental samples by means of several different experimental set ups.

In general, sampling procedures have been characterized till now by short time (tens of minutes to few hours) and low volume of aerosol collection (hundreds of liters to few cubic meters), but this kind of spot assessment appears a hardly representative monitoring for the environmental exposure scenarios in healthcare units classified as low risk settings; they can receive patients initially in not critical conditions, with evolving viral charge. The presence of airborne virus can be missed due to inadequate temporal coverage for capturing variability in virion emissions from patients and due to inadequate sample size.

When looking at outdoor studies, Setti et al. (2020b) found SARS-CoV-2 RNA in PM10 daily filters (24h at 2.3 m 3 /h) sampled before mitigation effects of lockdown containment measurements at an Italian industrial site, in the peculiar winter environmental conditions of the Po Valley (low mixing height and high particle numbers). Hadei et al. (2021) detected SARS-CoV-2 RNA in public places and transportations on TSP on PTFE and glass fiber filters for shorter times. These suggest an opportunity for considering 24h /full day samplings on filtering membranes also in indoor studies on airborne viral RNA.

Indeed, beside the studies on the viral RNA presence in aerosols, it is important to assess the potential infectivity of the collected samples. In this way, Comber et al. (2020) also presented four studies with infectivity assessment but in laboratory controlled conditions, where aerosols with SARS-CoV-2 were experimentally generated and the viral viability and integrity were investigated in different experimental settings. On the other hand, few studies tried to cultivate the virus from the aerosol, Zhou et al. (2020) and Binder (2020) failed in recovering infectious air samples, meanwhile Lednicky et al. (2020) and Santarpia et al. (2020a and 2020b) found evidence of SARS-CoV-2 amplification on Vero cells infected with air samples collected in real indoor environment. Even if airborne SARS-CoV-2 RNA detection on indoor particulate matter (PM) can be a tracer/indicator for potential exposure, viral RNA presence in the environment does not necessarily imply infectivity and thus effective risk of infection (Comber et al. 2020) ; so virus viability needs to be assessed. To date, since a universal consensus regarding the infectious potential of airborne SARS-CoV-2 is not achieved, precautions and preventive measures need to be undertaken (e.g. social distancing, facial masks), moreover, this holds in first instance for the safeguard of healthcare and J o u r n a l P r e -p r o o f medical personnel. After a review on studies related to health care worker protection, Zhang and Duchaine (2021) proposed a model of airborne transmission of SARS-CoV-2 involving inhalable particles (defined as the fraction of particles capable of penetrating into the head airways or below, upon inhalation (Milton, 2020): it excludes larger ballistic droplets but it includes particles larger than 5μm) and giving little relevance to thoracic and respirable particulates. The coarse fraction of PM10, can settle in the nose area rich in ACE-2 receptors and thus be considered as a relevant vehicle for SARS-CoV-2 infectivity, providing hints for aerodynamic size selection in sampling, and supporting statistical observational finding stronger correlation between COVID-19 outcomes in Italy during early stage of the pandemics with PM10 rather than with PM2.5 (Setti et al.2020c ).

Beside environmental monitoring of viral RNA presence, sound and informative risk assessment on SARS-CoV-2 transmission requires an infectivity assay that -at the present state of the knowledgeis performed by testing the potential infection on Vero E6 cells in BSL3 lab, directly, for available fresh environmental aerosol samples, adequately collected in liquids with dedicated instrumentation In the present work, results are reported from a short-term air monitoring campaign conducted in the tail of the first COVID-19 wave in Italy (June 2020) at a geriatric COVID-19 ward of the Ospedale Maggiore in Trieste (Italy). The findings have been interpreted based on the comparison of cycle threshold (Ct) from air monitoring with Ct and viral copies quantification obtained by infecting Vero E6 cells with clinical oral/nasal swabs specimens positive for SARS-CoV-2 RNA at the diagnostic analysis, observing the presence/absence of cytopathic effects on Vero E6 cells exposed to the clinical samples. Therefore, we show an indirect method for sampling -schemes not having implemented samplers dedicated to preserve virus viability, that could be used also for future epidemics.

Cycle threshold from air samples (Ct-as) can be compared to cycle threshold from lowest virion concentration -obtained by dilution of extracts from oral/nasal swabs collected from infected patients (Ct-dpt) -that provokes cytopathic effects on Vero E6 cells in BSL3 lab; if Ct-as exceeds Ct-dpt air samples have the potential of being infective.

With the aim of supporting an assessment of potential infectivity for daily environmental samples, a model study has been designed and performed, correlating the Ct of SARS-CoV-2 RNA from air sample, indicative of the quantity of nucleic acid present, and the viral load of nasopharyngeal samples collected in clinical practice with the results from infectivity assay on Vero E6 cells.

In order to assess feasibility of airborne RNA detection in healthcare indoor settings with daily coverage, aerosol potentially containing SARS-CoV-19, was collected on glass fiber filters with size selection as PM 10 operating daily for 24 hours, in a monitoring activity from 19 to 23 of June 2020, at the Geriatric ward of the Integrated University Health Authority Giuliano-Isontina (ASUGI) -Maggiore hospital of Trieste (Italy).

The Geriatric ward became a COVID-19 healthcare unit in late March 2020. During the pandemic emergency period it had dedicated and separated entrance and exit rooms that allow dressing of operators with personal protective equipment and access to the main corridor, and 13 rooms hosting COVID-19 patients.

A map of rooms of the Geriatric ward with the sampler position is reported in the supplemental materials ( fig. SM1 ). Table 1 reports for each sampling day, the number of positive patients in the Geriatric unit, the number of hosts with first diagnosis recent more than 10 days, the number of hosts having less than 10 day from first positivization, the number of hosts re-positivized after negativization. Sampling heads containing PM 10 on filters were brought in sealed bags to the BSL2 lab of the Functional Genomic Research Unit of the University of Trieste for SARS-CoV-2 molecular detection.

RNA from the filters has been extracted using the ZymoBIOMICS RNA Miniprep Kit

Zymoresearch, Irvine, CA, USA), modified as reported in (Setti et al., 2020b) . From half filter, using 1 ml of lysis buffer, it was possible to recover about 400 µl of solution which was then processed according to the protocol with a final eluate of 50 µl.

In parallel, we processed 1 brand-new spiked filter with 10 6 synthetic RNA molecules and 2 filters with environmental PM10 for air-quality monitoring spiked with 10 6 and 10 8 synthetic viral RNA molecules, to verify the efficiency of the extraction method. The synthetic viral RNA was kindly provided by Institute Pasteur, Paris.

For the assessment of viral RNA, given the particular origin of the sample, of qScript XLT 1-Step 

Twelve clinical swabs were collected from 12 COVID-19 patients enrolled at the emergency room (ER) of the Monfalcone hospital (ASUGI, Italy). All patients showed positivity for SARS-CoV-2 infection, after undergoing the molecular diagnostic test employed in the routine diagnostic practice of the Monfalcone hospital laboratory (Allplex SARS-CoV-2 assay, Seegene, Seoul, South Korea on the CFX connect Real Time PCR detection system, BioRad, Hercules, CA, USA). The swabs were preserved in universal transport medium (UTM) at 4°C until processed, 2 days after the collection.

Vero E6 The table 2 reports all the Ct data obtained in replica series performed to confirm these initial results. Moreover, all the amplicons were subjected to a melting curve analysis, high resolution gel electrophoresis and restriction enzyme analysis to confirm reaction specificity (data not shown). 

Partial SARS-CoV-2 RNA has been detected in airborne samples; however, the impact of these traces in terms of potential infectivity is yet not completely known. To this end, we designed a simple model of in vitro infectivity evaluation for the detection of the minimal viral quantity (expressed as threshold cycle, after Real Time semi-quantitative PCR) able to infect and replicate in host cells.

We collected twelve samples from swabs of patients attended at the ER of Monfalcone Hospital, whose positivity for SARS-CoV-2 infection was detected by RT QPCR (Allplex SARS-CoV-2 assay, Seegene, Seoul, South Korea). In table 3 we report the threshold cycle of each sample. To note, this kit did not allow the quantification of the viral load, however, it is known that the threshold cycle inversely correlated with the quantity of the virus. The specimens were subsequently seeded on Vero E6 cells, a permissive, in vitro widely accepted, host for SARS-CoV-2 replication. In Figure 2 ,2,4,6,8,9,10,12) , instead, where the cells are less viable due to the infection they tend to detach and the staining corresponding to a low number of cells is weak (patients 3,5,7,11, red circled).

The evolution of Ct and viral copy/ml measured at day 0, day 2, day 5 and day 7 in Vero cells inoculated with the 12 samples are reported in table 4, together with the evidence of presence (+) or absence (-) of cytopathic effect, supporting the infectivity assessment of the sample..The original viral quantity used to perform the infection is also showed. 

Only the specimens 3, 5, 7, 11 developed an evident cytopathic effect at the day 7 th , and their viral load increased at the time points investigated (2, 5 and 7 days after virus inoculation). For these samples the viral quantity used for infection is above E+10 viral copies. Instead, the other samples

were not able to replicate in this permissive cell culture (less than initial E+10 viral copies).

Therefore, E+10 viral copies (corresponding to Ct < 24) can be considered as a cutoff below which the samples maintained an infectivity potential.

The cytopathic effect could be thus considered unlikely for the environmental PM 10 samples,

showing amplification of viral RNA at Ct = 36 or higher.

The airborne transmission of SARS-CoV-2 is still under debate and the main health authorities, although recommending precautions when managing COVID-19 patients especially during procedures able to generate aerosol (e.g. tracheal intubation and dentistry), claim also the need for further research in this field (WHO, 2020; CDC, 2020; ECDC, 2020).

In the present work a short-term air monitoring was conducted at a geriatric COVID-19 healthcare facility in Trieste (Italy), where SARS-CoV-2 RNA traces were detected. Evidence of viral RNA presence reported in table 2 is coherent with those of the number of patients in the considered ward:

the first day of the monitoring presents the highest number of patients and positive RNA finding in sampled indoor PM10.

Previous detection of SARS-CoV-2 RNA (mostly partial viral nucleic acid) have been described in airborne samples; however, the impact of these traces in terms of potential infectivity has not been yet well characterized in a controlled univocal infection model.

We estimated the potential threshold of infectivity on Vero E6 cells in a set of 12 clinical swab specimens. Our experimental setting showed that E+10 viral copies (approximately equivalent to Ct<24) are able to generate a cytopathic effect, thus it can be considered as a cutoff below which the samples may maintain infectivity potential at least in vitro. In fact, it is technically difficult to predict if the same samples that are able to infect the Vero E6 cells belonged to an individual able to transmit SARS-CoV-2 to other people in a real situation. Nevertheless, our proposed model for infectivity assessment was previously suggested by Wölfel et al. (Wölfel et al. 2020 ) as a method for early discharge of COVID-19 patients from hospital to home isolation. The authors reported that when the initial viral load was above E+10 viral copies the proportion of positive viral culture was 100% but when the viral load was less than E+6 they never yielded viral amplification in vitro. So, they defined on the basis on in vitro cell culture that E+5 is the cutoff for patient discharge after 10 days of symptoms.

Other previous studies observed strong correlation between the initial threshold cycle and the success rate of virus amplification in Vero E6 cell culture being below 30% when the Ct was above 30 (Singanayagam et al. 2020; La Scola et al. 2020 , Yamada et al. 2020 ).

In our experiments the threshold for infectivity seems to be lower, however, some difference can be expected due to the different RNA isolation procedures and reagents, moreover, the two studies cited did not report the volumes employed for the extraction, RNA elution and real time PCR experiments that can affect the final results. To date, in the ECDC (European Centre for Disease Prevention and Control) guidelines, there is not yet a consensus on the Ct value that can be considered as an infectivity threshold and most of the laboratories and the diagnostic tests WHO approved reported only the positivity or negativity of the samples on the medical report with no assessment of the viral load (ECDC, 2020; WHO, 2020) . Our results are coherent with (Bullard et al., 2020) , that pointed to the need of extending studies on the subject. Furthermore, despite the daily increment of published papers with the keyword SARS-CoV-2 molecular diagnosis, most articles lack to define accurately the study procedures.

In our work, a successful detection of SARS-CoV-2 RNA in environmental air samples was achieved, although at that time we were not able to assess the potential infectivity of these air samples due to the lack of air-sampler able to preserve the virus integrity. The high Ct identified in this analysis, above the Ct threshold of infectivity later evaluated in vitro on Vero E6 cells, could suggest very low risk of infection in the monitoring locations at the geriatric unit.

Our results were in agreement with the previous measurements of SARS-CoV-2 RNA in air samples where low viral RNA quantity was commonly reported, as it can be seen in table supplementary 1 (Chia et al., 2020; Guo et al. 2020; Jiang et al. 2020; Lei et al. 2020; Razzini et al. 2020; Santarpia et al. 2020a; Santarpia et al. 2020b; Zhou et al. 2020 , Ding et al. 2021 Feng et al. 2021; Kenarkoohi et al. 2020) . However, other studies failed in evidencing SARS-CoV-2 RNA, but considering that air sampling was affected by several variables (e.g. protocol, timing), by the devices employed together with the degradable nature of nucleic acids, these divergences can occur (Comber et al. 2020) . It is important to note also that they could represent either real negative findings or false negative data. Studies on the persistence of RT-PCR diagnostic gene fragments on filters in sampling air flows could help in assessing the extent of potential analyte losses and eventual consequent risk underestimation.

The positive findings here reported were also in line with the epidemiologic studies of COVID-19 outbreaks. Interestingly, in different close environmental settings, (e.g. restaurant, choir practise, transport, healthcare facilities) clusters of infections with several COVID-19 cases were reported (Comber et al. 2020 ).

Nevertheless, when considering the possible environmental transmission of SARS-CoV-2, it is also important to estimate that different variables account to determine its infectious potentiality.

Indeed, the multiple release of the respiratory droplets containing the virus from infected people (e.g. when individuals speak aloud, spit, sneeze or cough) can increase the risk, especially in indoor environments, as well as the high viral load of the affected index cases. Interestingly, it has been reported in a mathematical model of SARS-CoV-2 spreading that a cough from an individual with high viral load could contain 7.44 million viral copies/m3 (Riediker et Tsai, 2020) ; moreover, the risk should increase in case of prolonged exposure and poor aerated inner settings. 0.25 to 0.50 μm size range, that is also the hardest to coagulate (too big for Brownian motions) or settle (too small for effective deposition). Remarkably, the viability of viruses once airborne depends on various factors (temperature, relative humidity, aerosol composition, solar radiation), as well as their resistance during sampling that could inactivate them, and moreover, the timing from air collection to sample absorption on Vero cells is crucial.

Therefore, the airborne transmission of SARS-CoV-2 remains still debated and needs more research to unravel the real contribution of this type of virus dissemination in the present pandemic, even if from the early notes on the pandemic WHO recommend precautions with COVID-19 patients during procedures generating aerosol, and both CDC and ECDC recommend airborne precautions during all stages of the care of COVID-19 patients.

Although the information about the presence of SARS-CoV-2 RNA in environmental samples can be alarming and require to be cautiously disseminated to the public, it is widely admitted that the only positivity of the molecular test is insufficient to draw definitive conclusions about the airborne transmission of SARS-CoV-2; thus, although an "indirect method" as the one presented in the current paper can provide indication about potential infection, it remains mandatory to set up and deploy methods for assessing the infectivity of the air samples collected in indoor environment at risk. J o u r n a l P r e -p r o o f

Environmental and aerosolized SARS-CoV-2 among hospitalized COVID-19 patients

Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples

Estimation of airborne viral emission: Quanta emission rate of SARS-CoV-2 for infection risk assessment

Air and environmental sampling for SARS-CoV-2 around hospitalized patients with coronavirus disease 2019 (COVID-19)

for the Singapore 2019 Novel Coronavirus Outbreak Research Team (2020) Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients

Airborne transmission of SARS-CoV-2 via aerosols

Discontinuous and Continuous Indoor Air Quality Monitoring in Homes with Fireplaces or Wood Stoves as Heating System

Toilets dominate environmental detection of severe acute respiratory syndrome coronavirus 2 in a hospital

Centre for Disease Prevention and Control (2020) Population-wide testing of SARS-CoV-2: country experiences and potential approaches in the EU

Multi-route transmission potential of SARS-CoV-2 in healthcare facilities

Crystal violet assay for determining viability of cultured cells

Exaggerated risk of transmission of COVID-19 by fomites

Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards

Presence of SARS-CoV-2 in the air of public places and transportation

An updated min-review on environmental route of the SARS-CoV-2 transmission

Clinical data on hospital environmental hygiene monitoring and medical staff protection during the coronavirus disease 2019 outbreak

Hospital indoor air quality monitoring for the detection of SARS-CoV-2 (COVID-19) virus

Air and Environmental Contamination Caused by COVID-19 Patients: a Multi-Center Study

Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards

Highly efficient collection of infectious pandemic influenza H1N1 virus (2009) through laminar-flow water based condensation

Viable SARS

CoV-2 in the air of a hospital room with COVID-19 patients

inter-personal distance could not be enough

Potential role of particulate matter in the spreading of COVID-19 in Northern Italy: First observational study based on initial epidemic diffusion

Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19

Risk of SARS-CoV-2 transmission by aerosols, the rational use of masks, and protection of healthcare workers from COVID-19

Recognition of aerosol transmission of infectious agents: a commentary

Airborne spread of infectious agents in the indoor environment

Virological assessment of hospitalized patients with COVID-2019

World Health Organization (2020) Molecular assays to diagnose COVID-19: Summary table of available protocols

Virus Diagnosis Group (NIID Toyama). (2021) Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using

Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship

SARS-CoV-2 and health care worker protection in low-risk settings: A review of modes of transmission and a novel airborne model involving inhalable particles

Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London

The authors gratefully thank TCR-Tecora S.R.L. for providing instrumentation for operativity of BSL3 laboratory.